COMPANY

Bayer AG

FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

Also known as Bayer, Bayer BioPartnering Solutions · 50 sources

Profile checked Oct 10, 2026

Keywords: Chronic Kidney Disease Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Metastatic Hormone-sensitive Prostate Cancer Type 2 Diabetes Mellitus Contrast Enhancement in Magnetic Resonance Imaging HER2 Mutation Proteinuria Non-metastatic Castration-resistant Prostate Cancer Hemophilia A Pulmonary Hypertension Central Nervous System Pathology Atrial Fibrillation Stable Coronary Artery Disease Advanced/Metastatic Colorectal Adenocarcinoma Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion Venous Thromboembolism Prostatic Neoplasms Transthyretin Amyloid Cardiomyopathy Type 2 Diabetes Chronic Kidney Disease (CKD) Stages G2 to G3b Vasomotor Symptoms (VMS) Associated With Menopause Metastatic Castration-resistant Prostate Cancer Low-volume Metastasis Sepsis Coagulopathy Renal Anemia Drug-drug Interaction Retinopathy of Prematurity Preterm Infants HER2 Mutation Advanced Non-small Cell Lung Cancer Advanced Solid Tumors Harboring KRAS G12C Mutation Alport Syndrome MTAP-deleted Solid Tumors Parkinson's Disease Chronic Heart Failure With Reduced Ejection Fraction Estrogen Therapy

1,674Trials (company is sponsor)

Timeline

Sep 1, 2027 Trial start —: A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) source ↗
Jan 1, 2027 Trial start Phase 1: A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease source ↗
Nov 30, 2026 Trial start —: An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States source ↗
Oct 15, 2026 Trial start —: A Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer in India source ↗
Oct 15, 2026 Trial start —: Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor source ↗
Sep 30, 2026 Trial start —: A Study to Learn More About How Well Finerenone Works in Real-World in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social) source ↗
Sep 7, 2026 Trial start —: Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy source ↗
Sep 1, 2026 Trial start Phase 2: A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation source ↗
Aug 31, 2026 Trial start —: An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their source ↗
Aug 21, 2026 Trial start 1: Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body source ↗
Jul 31, 2026 Trial start —: An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That source ↗
Jul 28, 2026 Trial start Phase 1: A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in source ↗
Jul 22, 2026 Trial start Phase 1: Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants source ↗
Jul 21, 2026 Trial start —: A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications source ↗
May 29, 2026 Trial start Phase 1: A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants source ↗
Apr 27, 2026 Trial start Phase 2: A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer. source ↗
Apr 7, 2026 Trial start Phase 1: A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation source ↗
Feb 13, 2026 Trial start Phase 4: A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis source ↗
Nov 20, 2025 Trial start —: An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South source ↗
Nov 19, 2025 Trial start Phase 2: A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome source ↗
Oct 29, 2025 Trial start —: A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting source ↗
Mar 21, 2025 Trial start Phase 1/Phase 2: A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors source ↗
Mar 12, 2025 Trial start Phase 1: A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy source ↗
Feb 28, 2025 Trial start —: An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Ca source ↗
Feb 28, 2025 Trial start Phase 1: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer source ↗

Showing 25 of 50 dated events.

Upcoming milestones

Oct 7, 2026 (ESTIMATED) · Phase 1 · A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body · NCT07722585
Oct 30, 2026 (ESTIMATED) · · An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Re · NCT07795606
Dec 25, 2026 (ESTIMATED) · Phase 1 · A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy · NCT06854640
Dec 29, 2026 (ESTIMATED) · Phase 1 · A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants · NCT07652723
Jan 31, 2027 (ESTIMATED) · Not phased · A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine · NCT06772025
Feb 22, 2027 (ESTIMATED) · Phase 1 · Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants · NCT07762287
Mar 31, 2027 (ESTIMATED) · · An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK) · NCT06315556
Apr 10, 2027 (ESTIMATED) · Phase 3 · A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE In · NCT05196035

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) Showing 50 of 1,674

Record	Title	Phase	Status	Start	Primary completion
NCT07232537	An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea	Not listed	Active, not recruiting	Nov 20, 2025	Sep 30, 2027 (estimated)
NCT05915702	A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems	Phase 3	Completed	Jul 24, 2023	May 30, 2024 (actual)
NCT07235462	A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting	Not listed	Recruiting	Oct 29, 2025	Apr 30, 2028 (estimated)
NCT07625215	A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation	Phase 2	Recruiting	Sep 1, 2026	May 16, 2030 (estimated)
NCT07806591	A Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer in India	Not listed	Not yet recruiting	Oct 15, 2026	Nov 15, 2028 (estimated)
NCT06874114	An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care	Not listed	Completed	Feb 28, 2025	Jun 30, 2026 (actual)
NCT07431294	A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease	Phase 1	Not yet recruiting	Jan 1, 2027	May 7, 2027 (estimated)
NCT07535112	A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation	Phase 1	Recruiting	Apr 7, 2026	Jul 27, 2029 (estimated)
NCT04142437	Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body	Not listed	Recruiting	Apr 3, 2020	Nov 30, 2029 (estimated)
NCT05900388	A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)	Not listed	Not yet recruiting	Sep 1, 2027	Jun 30, 2029 (estimated)
NCT06760819	A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)	Phase 2	Recruiting	Feb 13, 2025	Feb 2, 2029 (estimated)
NCT04736199	Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer	Phase 3	Completed	Feb 23, 2021	Jun 7, 2024 (actual)
NCT07298044	A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis	Phase 4	Recruiting	Feb 13, 2026	Jul 15, 2027 (estimated)
NCT07841015	A Study to Learn More About How Well Finerenone Works in Real-World in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)	Not listed	Not yet recruiting	Sep 30, 2026	Dec 31, 2027 (estimated)
NCT05457283	A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria	Phase 3	Recruiting	Nov 8, 2022	Aug 7, 2028 (estimated)
NCT07557147	Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor	Not listed	Not yet recruiting	Oct 15, 2026	Apr 15, 2028 (estimated)
NCT07490431	An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States	Not listed	Not yet recruiting	Nov 30, 2026	Nov 30, 2029 (estimated)
NCT06052306	A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)	Phase 1	Active, not recruiting	Sep 20, 2023	Jun 8, 2027 (estimated)
NCT06608212	An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States	Not listed	Completed	Oct 9, 2024	Mar 31, 2025 (actual)
NCT06661122	A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer	Not listed	Recruiting	Nov 18, 2024	Mar 31, 2031 (estimated)
NCT06854640	A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy	Phase 1	Recruiting	Mar 12, 2025	Dec 25, 2026 (estimated)
NCT04899661	A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia	Not listed	Active, not recruiting	Aug 6, 2021	Jun 30, 2027 (estimated)
NCT07652723	A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants	Phase 1	Recruiting	May 29, 2026	Dec 29, 2026 (estimated)
NCT06315556	An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)	Not listed	Recruiting	Mar 5, 2024	Mar 31, 2027 (estimated)
NCT06334120	An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea	Not listed	Recruiting	Sep 25, 2024	Mar 31, 2028 (estimated)
NCT06452277	A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)	Phase 3	Recruiting	Aug 28, 2024	Oct 28, 2027 (estimated)
NCT06659341	A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation	I	Recruiting	Nov 8, 2024	Apr 26, 2027 (estimated)
NCT03588299	Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"	Phase 1/Phase 2	Completed	Nov 7, 2018	Sep 15, 2026 (actual)
NCT07722585	A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body	Phase 1	Recruiting	Jul 28, 2026	Oct 7, 2026 (estimated)
NCT02562235	Riociguat in Children With Pulmonary Arterial Hypertension (PAH)	Phase 3	Active, not recruiting	Oct 29, 2015	Mar 7, 2020 (actual)
NCT06246643	A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies	Phase 2	Active, not recruiting	Jan 24, 2024	Apr 27, 2028 (estimated)
NCT07211685	A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome	Phase 2	Active, not recruiting	Nov 19, 2025	Nov 29, 2027 (estimated)
NCT07791160	Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy	Not listed	Recruiting	Sep 7, 2026	Dec 31, 2028 (estimated)
NCT05059236	A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.	Phase 2	Completed	Nov 4, 2021	May 30, 2025 (actual)
NCT06914128	A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors	Phase 1/Phase 2	Recruiting	Mar 21, 2025	Jun 18, 2029 (estimated)
NCT02941783	Drug Use Investigation of Kovaltry in Hemophilia A Patients	Not listed	Completed	Nov 30, 2016	Mar 23, 2022 (actual)
NCT07330258	A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications	Not listed	Recruiting	Jul 21, 2026	Dec 21, 2032 (estimated)
NCT06486844	An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany	Not listed	Completed	Jul 5, 2024	Aug 31, 2025 (actual)
NCT07795606	An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes	Not listed	Not yet recruiting	Aug 31, 2026	Oct 30, 2026 (estimated)
NCT05196035	A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria	Phase 3	Active, not recruiting	Mar 28, 2022	Apr 10, 2027 (estimated)
NCT06772025	A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine	Not phased (device or behavioral study)	Recruiting	Feb 3, 2025	Jan 31, 2027 (estimated)
NCT05915728	A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)	Phase 3	Completed	Jul 24, 2023	May 31, 2024 (actual)
NCT01065454	A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction	Phase 2	Terminated	Apr 14, 2010	Jun 6, 2012 (actual)
NCT06764316	A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer	Phase 1	Recruiting	Feb 28, 2025	Jul 31, 2029 (estimated)
NCT07538843	An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment	Not listed	Recruiting	Jul 31, 2026	Nov 1, 2029 (estimated)
NCT07762287	Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants	Phase 1	Recruiting	Jul 22, 2026	Feb 22, 2027 (estimated)
NCT05099172	First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)	Phase 1/Phase 2	Recruiting	Oct 25, 2021	Mar 16, 2026 (actual)
NCT05858164	A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors	Phase 1	Completed	Aug 7, 2023	Sep 26, 2025 (actual)
NCT07450599	A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.	Phase 2	Recruiting	Apr 27, 2026	Oct 15, 2028 (estimated)
NCT07753252	Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body	1	Not yet recruiting	Aug 21, 2026	Sep 21, 2026 (estimated)